Supplementary Figure Legends 1-3 from Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Supplementary Figure 1 from Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Supplementary Tables 1-3 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
Supplementary Table 5 from Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
PDF file - 102K, ErbB2KI mammary tumor cells exhibit co-expression of Krt8 and Krt5.
PDF file, 78KB, Supplementary Figure 2: Deregulation of cyclin E in tamoxifen-resistant cells. MCF-7C and TAMR cells were treated with vehicle, OH-Tam (100 nM) or fulvestrant (10 nM). A: S phase percentage derived from flow cytometry of propidium iodide-stained cells. B: Densitometry of Western blots using GAPDH as a loading control. Data represent the mean range of duplicate experiments.
Supplementary Data from Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer
Supplementary Figure Legends 1-2, Table Legend from Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
Supplementary Table 4 from Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
PDF file - 139K, ErbB2KI mammary tumors express basal/myoepithelial markers and contain cells co-expressing Krt8 and Krt14.
PDF file - 104K, Comparison of ErbB2KI, MMTV/NIC, and other transgenic mouse models of breast cancer.
PDF file - 115K, ErbB2KI/shCtnnb1-derived mammary tumors show impaired β-catenin signalling.
PDF file - 153K, Inhibition of b-catenin signalling impacts on proliferative and transcriptional properties of basal breast cancer line.
Supplementary Figure 3 from Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Supplementary Figure 2 from Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
Supplementary Figure 2 from The Helix-Loop-Helix Protein Id1 Requires Cyclin D1 to Promote the Proliferation of Mammary Epithelial Cell Acini
Elizabeth A. Musgrove合作论文数University of Glasgow146Susan M Henshall合作论文数60
Sandra O'Toole合作论文数Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital53
Phillip Stricker合作论文数Garvan Institute of Medical Research;Department of Urology, St Vincent’s Private Hospital and Clinic;HMO St Vincent’s Hospital;The Kinghorn Cancer Centre;The Australian Prostate Cancer Research Centre – New South Wales;St. Vincent’s Prostate Cancer Research Centre;Department of Surgery, University of New South Wales Australia;Sydney Medical School, University of Sydney;School of Medicine, University of Western Sydney50SM Henshall合作论文数48
Ewan Millar合作论文数School of Clinical Medicine, University of New South Wales;NSW Health Pathology41
Andrew Biankin合作论文数Wolfson Wohl Cancer Research Centre, University of Glasgow;Glasgow Precision Oncology Laboratory, University of Glasgow;Gabriel Precision Oncology;ICGC ARGO;Cancer Research UK;Precision-Panc41
Lisa Horvath合作论文数Garvan Institute of Medical Research, Kinghorn Cancer Centre;Chris O'Brien Lifehouse;Medical Oncology, University of Sydney40
Roger Daly合作论文数Daly Laboratory, Department of Biochemistry and Molecular Biology, Monash University37Kench James G合作论文数Canc Res Program, Garvan Inst Med Res34
Alexander Swarbrick合作论文数The Kinghorn Cancer Centre, Garvan Institute of Medical Research;St Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney31
James Kench合作论文数Royal Prince Alfred Hospital;University of Sydney27Ckw Watts合作论文数26Ormandy Christopher J合作论文数25Jj Grygiel合作论文数23
David I Quinn合作论文数Department of Medicine, Keck School of Medicine, University of Southern California23Krishan K. Rasiah合作论文数Sydney22
Liz Caldon合作论文数Garvan Institute of Medical Research21Neville Hacker合作论文数Royal Hospital for Women20
Christopher J. Scarlett合作论文数Department of Surgery, Royal North Shore Hospital20Csl Lee合作论文数19
C.Marcelo Sergio合作论文数19D Segara合作论文数18Michael Keeney合作论文数18Watts C K合作论文数18Alison J. Butt合作论文数Kolling Institute of Medical Research;University of Sydney;Royal North Shore Hospital;Kolling Institute of Medical Research, University of Sydney18
Mark Pinese合作论文数Cancer Research Program, Garvan Institute of Medical Research17
Anne Maree Haynes合作论文数17Anna deFazio合作论文数School of Medicine Sciences, Faculty of Medicine and Health, The University of Sydney16Emily Colvin合作论文数School of Medicine Sciences, Faculty of Medicine and Health, The University of Sydney16Illingworth Andrea合作论文数16Elena Lopez Knowles合作论文数The Institute of Cancer Research16
Jason S. Carroll合作论文数Cancer Research UK Cambridge Institute, University of Cambridge16Philippa M. O'Brien合作论文数Cancer Research Program, Garvan Institute of Medical Research;St Vincent's Clinical School, University of NSW16Lee Cheok Soon合作论文数15
Wayne Tilley合作论文数University of Adelaide, University of Adelaide15Warick Delprado合作论文数15PC Brenner合作论文数13Gillian M. Lehrbach合作论文数12Ruth Pe Benito合作论文数Cota Inc12David Golovsky合作论文数12Christine L. Clarke合作论文数12
Marina Pajic合作论文数Children's Cancer Institute Australia for Medical Research12Adrienne Morey合作论文数Medical School, College of Health and Medicine, The Australian National University11Susan J. Clark合作论文数11
Radhika Nair合作论文数11Leigh C. Murphy合作论文数11Boris Sarcevic合作论文数St. Vincent's Institute of Medical Research and Department of Medicine, The University of Melbourne11
Catriona McNeil合作论文数Chris O’Brien Lifehouse11
